Targeted Combined Endpoint Improvement in Patient and Disease Domains in Atopic Dermatitis: A Treat-to-Target Analysis of Adults with Moderate-to-Severe Atopic Dermatitis Treated with Upadacitinib

A treat-to-target approach was recently developed to guide systemic treatment for adults with atopic dermatitis (AD). Recommendations outlined criteria for a 3-month initial acceptable treatment target and a 6-month optimal target, evaluated using global assessment of patient-reported disease severi...

詳細記述

書誌詳細

主要な著者:	Shawn G. Kwatra, Marjolein de Bruin-Weller, Jonathan I. Silverberg, Peter Lio, Mette Deleuran, Handan Aydin, Brian M. Calimlim, Michael C. Lane, Yingyi Liu, Sarah Ofori, Stephan Weidinger
フォーマット:	Artigo
言語:	Inglês
出版事項:	Medical Journals Sweden 2024-05-01
シリーズ:	Acta Dermato-Venereologica
主題:	atopic dermatitis itch Janus kinase inhibitor skin clearance treat-to-target upadacitinib
オンライン･アクセス:	https://medicaljournalssweden.se/actadv/article/view/18452
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!